Legal Representation
Attorney
Robert A. Rowan
USPTO Deadlines
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 13, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 13, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 5, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 4, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 31, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 4, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 31, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 19, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 9, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 7, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 7, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 7, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 7, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 5, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 5, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 5, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 7, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 5, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 5, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 5, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 7, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 5, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 5, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 5, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 6, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 11, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 11, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 22, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 3, 2017 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 23, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 8, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 8, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 31, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 11, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 19, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 19, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 19, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 13, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 5, 2016 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 4, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes, prescription drugs for the treatment of iron-associated neurodegenerative conditions, namely, Parkinson's disease and neurodegeneration with brain iron accumulation, in particular, pantothenate kinase-associated neurodegeneration
Additional Information
Design Mark
The mark consists of the word "APOPHARMA" with "USA" underneath and a swoosh design at the end.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
APO PHARMA USA
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"USA"